Xeloda (capecitabine)

Capecitabine is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Capecitabine is classified as an antimetabolite.

Xeloda is indicated for the treatment of:

or the adjuvant treatment of patients following surgery of stage III colon cancer.
metastatic colorectal cancer.
first-line treatment of advanced gastric cancer in combination with a platinum-based regimen.
in combination with docetaxel for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. Previous therapy should have included an anthracycline.
as monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline-containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.